Management of Non Proliferative Diabetic Retinopathy (NPDR) through Ayurveda - A Case Report
Abstract
Introduction: Diabetic Retinopathy (NPDR) is a micro vascular complication of diabetes that affects the retina and is a leading cause of blindness in working-age adults, with a national prevalence of 12.5% for Diabetic Retinopathy and 4.0% for VTDR. Ayurveda prioritizes eye health and offers specialized treatments under Netra Kriyakalpa, with Netra Tarpana specifically indicated for nourishing ocular structures.
Objectives: To evaluate the therapeutic efficacy of Sadyovirechana and Shatahvadi Ghrita Netra Tarpana in the management of Pramehajanya Timira (Non-proliferative Diabetic Retinopathy), through assessing improvements in visual function, retinal health.
Methodology: A 52-year-old male patient, who is a known case of Type 2 Diabetes Mellitus since 10 years visited Shalakya Tantra OPD at JSSAMC&H with the complaints of blurring of vision since 6 months and on evaluation he was diagnosed with Non proliferative Diabetic Retinopathy. Based on the Nidana (Causative factors) and Samprapthi (Pathogenesis) of Prameha (Diabetes Mellitus) the ocular complications were understood and the following treatment plan was adopted.
- Sadyovirechana (Therapeutic Purgation): Gandharvahastadi Eranda Taila administered for one day to eliminate systemic toxins.
- Netra Tarpana (Ocular Nourishing Treatment): Shatahvadi Ghrita administered for seven days to nourish ocular tissues and stabilize retinal function.
Observations & Results: Post-treatment evaluation indicated improved visual acuity in Snellen’s distant vision chart from 6/12 to 6/9 in Right eye, and 6/9 to 6/6 in Left eye. Near vision improved from N9 to N6 in the right eye, while it remained N6 in the left eye. HbA1c level reduced from 8.8% before treatment to 7.6% after treatment. Retinal haemorrhages were reduced, and retinal vascular integrity was enhanced through Direct Ophthalmoscopy and colour fundus photograph. Subjective improvement was reported in clarity of vision, reduced blurriness, and overall ocular comfort. No adverse effects were observed.
Conclusion: This case study highlights the potential of Ayurveda interventions in managing NPDR by integrating detoxification, ocular nourishment therapies. This treatment has an important role as therapeutic and prophylactic measure for Non proliferative Diabetic Retinopathy.
References
2. Frank RN, Keirn RJ, Kennedy A, et al. Galactose induced retinal capillary basement membrane thickening: prevention by sorbinil. Invest Ophthalmol Vis Sci. 1983;24(11):1519-24.
3. Wong TY, Sabanayagam C. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence. Ophthalmologica. 2020;243(1) :9-20. doi:10.1159/000502387. Epub 2019 Aug 13. PMC ID: 31408872.
4. Raman, Rajiv Bhende, Pramod et al Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectional screening study, The Lancet Global Health, Volume 10, Issue 12, E1764 - E1773
5. Chisha Y, Terefe W, Assefa H, et al. Prevalence and factors associated with diabetic retinopathy among diabetic patients at Arbaminch General Hospital, Ethiopia: Cross sectional study. PloS one. 2017;12(3):171987
6. Alharthi AS, Almutairi MZK, Alswat AHK, et al. Prevalence and Potential Risk Factors of Diabetic Retinopathy among Type 2 Diabetics Patients in Diabetic Center, Taif City. The Egyptian Journal of Hospital Medicine. 2018;70(9):1455–1463.
7. Vagbhata, Ashtangahrdayam Vidyotini Commentary by Kaviraj Atridev Gupta Edited by Vaidya Yadunandan Upadhyaya Varansi: Chaukhambha Sanskrit Bhavan; Reprint 2008, Uttarastahana 13/58-59, p. 600
8. Sushruta. Sushruta Samhita, Sharira Sthana 3/17. Commentary: Dalhaṇa. Varanasi: Chaukhamba Orientalia; 2012. p.356.
9. Mishra B. Bhava Prakasha Nighantu. Chunekar KC, editor. Varanasi: Chaukhambha Bharati Academy; 2010. Madhyama Khanda, Adhaya 4.
10. Gupta MK, Sharma PK, Singh R, Ansari SH. Antioxidant activity of the methanolic extract of Ricinus communis leaves. Asian J Chem. 2007;19(5):3387 92
11. Yu XY, Lin SG, Zhou ZW, et al. Glabridin protects human retinal pigment epithelial cells from oxidative stress-induced apoptosis. Mol Vis. 2017;23:991-1002.
12. Wang CY, Kao TC, Lo WH, Yen GC. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions. J Agric Food Chem. 2011;59(14):7726-7733.
13. Erkan N, Ayranci G, Ayranci E. Antioxidant activities of rosmarinic acid. J Food Sci. 2008;73(5):C365-C368.
14. Badhani B, Sharma N, Kakkar R. Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications. RSC Adv. 2015;5:27540-27557.
15. Li R, Wang Y, Liu Y, et al. Quercetin attenuates diabetic retinopathy by inhibiting the NLRP3 inflammasome and NF-κB pathway. Exp Eye Res. 2020;201:108273.
16. Guardia T, Rotelli AE, Juarez AO, Pelzer LE. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco. 2001;56(9):683-687.
17. Park C, Choi EO, Kim GY, et al. Protective Effect of Kaempferol on Advanced Glycation End Products-Induced Mesangial Cell Apoptosis and Oxidative Stress. Int J Mol Sci. 2019;20(11):2749.
18. Hu PF, Wang YQ. Berberine inhibits HIF-1α expression and VEGF secretion in human retinal pigment epithelial cells under hypoxic conditions. Int J Ophthalmol. 2018;11(8):1283-1289.
19. Doucette CD, Hilchie AL, Liwski R, Hoskin DW. Piperine, a dietary phytochemical, inhibits angiogenesis. J Nutr Biochem. 2013;24(1):231-239.
20. Kessler M, Ubeaud G, Jung L. Anti- and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol. 2003;55(1):131-142.
21. Panchal SK, Brown L. Quercetin and Rutin in the Prevention and Treatment of Cardiovascular Diseases. In: Quercetin: Dietary Sources, Functions and Health Benefits. Nova Science Publishers; 2012:1-20.
22. Munshi R, Karande-Patil S, Kumbhar D, Deshmukh A, Hingorani L. A randomized, controlled, comparative, proof-of-concept study to evaluate the efficacy and safety of Nisha-Amalaki capsules in prediabetic patients for preventing progression to diabetes. J Ayurveda Integr Med. 2023;14(6):100806.
23. Badisa SV, Ashwini MJ, Sneha PK, Resmi KK. Clinical study on combined effect of Vasakadi Kvatha and Katakadi Anjana in the management of diabetic retinopathy (Mehaja Timira). World J Pharm Pharm Sci. 2022;11(9):1078-1089.
